Vision Films To Release Feature 'The Evil Fairy Queen'
A Modern Good Versus Evil Fairy Tale Based on European Folklore
Lured to a beautiful but remote farmhouse by a deceitful relative, a family decides to move in. Little do they know it's in the middle of a dying kingdom of fairies and the only way for them to rejuvenate their life force is by sacrificing the family's young daughter. As she is baited to the fairies' lair, her mother must fight to return her to safety and bring an end to the evil fairy queen's reign.
Watch the trailer: https://youtu.be/SGhPzbn7mSg
Drawing on his knowledge of cryptozoology and folklore over the last 40 years, writer/producer James Wrench created a world where fairies are real and interact with humans. The fairies of The Evil Fairy Queen are based on genuine European folklore, not the fairies of modern children's stories, but supernatural beings full of malice who use humans as tools and playthings to fulfil their own desires and needs. Look for Wrench in the film, fittingly portraying the folklore expert "
The family at the heart of the film features real-life mother and daughter
Director
The Evil Fairy Queen will be available on major streaming and cable platforms across the US and
About Vision Films
Vision Films is a leading independent sales and VOD aggregator specializing in the licensing, marketing, and distribution of over 800 feature films, documentaries, and series from some of the most prolific independent film producers in the world. Led by
About M and M Film Productions
M and M Film Productions & M and M Film Productions International is a
Media contact:
[email protected]
8184159442
View original content to download multimedia:https://www.prnewswire.com/news-releases/vision-films-to-release-feature-the-evil-fairy-queen-302094544.html
SOURCE Vision Films, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Despite Rising Costs, Americans Refuse to Give Up Summer Vacation, Priceline's 2026 State of Summer Travel Report Finds
- Ascletis Announces U.S. FDA IND Clearance for Phase I Study of Once-Monthly Subcutaneously Administered GLP-1R/GIPR Dual Peptide Agonist, ASC35, for the Treatment of Obesity
- CGI's Insula platform supports AI-driven Earth observation in ESA's Φsat-2 mission
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share